Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.63 |
| ▸ | MGLL | Q99685 | 6/20 | 0.62 |
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.43 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30302146 | 0.89 | FAAH (0.80) | FAAHMGLLABHD6PLA2G7 | |
| SCHEMBL20567214 | 0.89 | FAAH (0.80) | FAAHMGLLABHD6PLA2G7 | |
| SCHEMBL25829817 | 0.88 | FAAH (0.65) | FAAHMGLLABHD6PLA2G7ALDH1A1 | |
| SCHEMBL24970592 | 0.88 | FAAH (0.76) | FAAHMGLL | |
| SCHEMBL25487326 | 0.87 | FAAH (0.51) | FAAHMGLL | |
| SCHEMBL25487209 | 0.87 | FAAH (0.50) | FAAHMGLL | |
| SCHEMBL25488229 | 0.86 | MGLL (0.79) | FAAHMGLLABHD6PLA2G7ALDH1A1 | |
| SCHEMBL25487179 | 0.83 | MGLL (0.51) | FAAHMGLLALDH1A1 | |
| SCHEMBL24971297 | 0.82 | FAAH (0.77) | FAAHMGLLABHD6PLA2G7 | |
| SCHEMBL16577083 | 0.81 | MGLL (0.56) | FAAHMGLLABHD6PLA2G7PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
| US-11655217-B2 | Pyrazole MAGL inhibitors | H. LUNDBECK A/S (DK) | 2023-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | FAAH 33/4885MGLL 1/4885ABHD6 40/4885 |
| US-11655217-B2 | Pyrazole MAGL inhibitors | MGLL, PNLIP, LPL | FAAH 32/4885MGLL 1/4885ABHD6 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.